<head>
    <link rel="stylesheet" href="styles.css">

    <style>
        @import url('https://fonts.googleapis.com/css2?family=Roboto&family=Roboto+Slab:wght@400;600&display=swap');
        </style>

    </head>
    
    <script src="index.js"></script>



    <body id="omicron">
        <a href="https://fullaccesssciencetoday.github.io/info/">
            <img src="pictures\F.A.S.T.jpg"
            width=300" height="125">
         </a>
        <br>
        <br>
        

        <h1 class="tittle">COVID-19 Traitements précoces</h1>
     

        <p class="description">
            Des traitements précoces et préventifs très efficaces, sûrs, bien connus et très peu coûteux ont été
            largement utilisés dans le monde entier, mais ne sont pas mis en œuvre dans les protocoles
            hospitaliers des nations les plus développées <a href="https://imrpress.com/journal/RCM/21/4/10.31083/j.rcm.2020.04.264" target="_blank">(McCullough et al., 2020)</a>. Néanmoins, de nombreux
            médecins indépendants emploient ces traitements (ou en tant que propholaxie, <a href="https://www.cureus.com/articles/82162-ivermectin-prophylaxis-used-for-covid-19-a-citywide-prospective-observational-study-of-223128-subjects-using-propensity-score-matching" target="_blank"> Kerr et al. 2022)</a>
            avec beaucoup de succès. Il s'agit notamment de l'ivermectine (par exemple : <a href="https://www.cureus.com/articles/63131-ivermectin-as-a-sars-cov-2-pre-exposure-prophylaxis-method-in-healthcare-workers-a-propensity-score-matched-retrospective-cohort-study" target="_blank">Morgenstern et al. 2021</a> ,
            ; <a href="https://www.medrxiv.org/content/10.1101/2021.05.31.21258081v1" target="_blank">( Biber et al., 2021)</a> de l'hydroxychloroquine (par exemple ; <a href="https://imrpress.com/journal/RCM/21/4/10.31083/j.rcm.2020.04.264" target="_blank">(McCullough et al., 2020)</a>
            <a href="https://www.sciencedirect.com/science/article/pii/S1477893920302179?via%3Dihub" target="_blank"> Million et al., 2020</a> ; 
            <a href="https://pubmed.ncbi.nlm.nih.gov/33042552/" target="_blank">Prodromos et
                Rumschlag, 2020)</a> 
                et de la vitamine D (par exemple : <a href="https://www.frontiersin.org/articles/10.3389/fpubh.2020.00513/abstract" target="_blank">Benskin, 2020</a>  ;
              <a href="https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7973108/" target="_blank">Teshome et al., 2021</a>  ;
              <a href=" https://www.sciencedirect.com/science/article/pii/S258993682100030X" target="_blank">Vassiliou et al., 2021</a> ).
        </p>

        <br>
        <br>
        <h1 class="tittle"> Articles scientifiques</h1>

        McCullough, Peter A. et al., Multifaceted highly targeted sequential multidrug treatment of early
        ambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev. Cardiovasc. Med. 2020, 21(4), 517–
        530. https://doi.org/10.31083/j.rcm.2020.04.264
        <br>
        <br>
        https://imrpress.com/journal/RCM/21/4/10.31083/j.rcm.2020.04.264
        <br>
        -------------------------------
        <br>
        Kerr L, Cadegiani F A, Baldi F, et al. (January 15, 2022) Ivermectin Prophylaxis Used for COVID-19: A
        Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching.
        Cureus 14(1): e21272. doi:10.7759/cureus.21272
        <br>
        <br>
        
        https://www.cureus.com/articles/82162-ivermectin-prophylaxis-used-for-covid-19-a-citywide-prospective-observational-study-of-223128-subjects-using-propensity-score-matching
        
        <br>
        -------------------------------
        <br>

        Morgenstern J, Redondo J N, Olavarria A, et al. (August 26, 2021) Ivermectin as a SARS-CoV-2 Pre-
        Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective
        <br>
        <br>
        Cohort Study. Cureus 13(8): e17455. doi:10.7759/cureus.17455
        <br>
        <br>
        
        https://www.cureus.com/articles/63131-ivermectin-as-a-sars-cov-2-pre-exposure-prophylaxis-method-in-healthcare-workers-a-propensity-score-matched-retrospective-cohort-study
        
        <br>
        -------------------------------
        <br>
        Biber, A., Mandelboim, M., Harmelin, G., Lev, D., Ram, L., Shaham, A., et al. (2021). Favorable
        outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized
        patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial. medRxiv,
        2021.05.31.21258081.
        <br>
        <br>
        https://www.medrxiv.org/content/10.1101/2021.05.31.21258081v1
        <br>
        -------------------------------
        <br>
        Million, M., Lagier, J.-C., Gautret, P., Colson, P., Fournier, P.-E., Amrane, S., et al. (2020). Early
        treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis
        of 1061 cases in Marseille, France. Travel Medicine and Infectious Disease, 35, 101738.
        <br>
        <br>
        https://www.sciencedirect.com/science/article/pii/S1477893920302179?via%3Dihub
        <br>
        -------------------------------
        <br>
        Prodromos C, Rumschlag T. Hydroxychloroquine is effective, and consistently so when provided
        early, for COVID-19: a systematic review. New Microbes New Infect. 2020;38:100776.
        doi:10.1016/j.nmni.2020.100776
        <br>
        <br>
        https://pubmed.ncbi.nlm.nih.gov/33042552/
        <br>
        <br>
        https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7534595/
        <br>
        -------------------------------
        <br>
        Benskin, Linda, (2020). A Basic Review of the Preliminary Evidence that COVID-19 Risk and Severity Is
        Increased in Vitamin D Deficiency. Frontiers in Public Health
        <br>
        <br>
        https://www.frontiersin.org/articles/10.3389/fpubh.2020.00513/abstract, Available at
        SSRN: https://ssrn.com/abstract=3669379
        <br>
        <br>
        https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3669379
        <br>
        -------------------------------
        <br>


        Teshome A, Adane A, Girma B, Mekonnen ZA. The Impact of Vitamin D Level on COVID-19
        Infection: Systematic Review and Meta-Analysis. Front Public Health. 2021;9:624559. Published 2021
        Mar 5. doi:10.3389/fpubh.2021.624559
        <br>
        <br>
        https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7973108/
        <br>
        -------------------------------
        <br>
        Vassiliou, A. G., Jahaj, E., Orfanos, S. E., Dimopoulou, I., & Kotanidou, A. (2021). Vitamin D in
        infectious complications in critically ill patients with or without COVID-19. Metabolism Open, 11,
        100106. http://doi.org/https://doi.org/10.1016/j.metop.2021.100106
        <br>
        <br>
        https://www.sciencedirect.com/science/article/pii/S258993682100030X